Explore breakthrough studies in transcriptomics, epigenetics, and genome editing techniques driving functional genomics forward.
Discover how SOX17 gene disruptions and its collaborator FUBP1 trigger pulmonary arterial hypertension (PAH) and the promising therapies emerging from these insights.